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Background
Systemic sclerosis (SSc) is characterised by vascular dys-
function and multi-organ fibrosis, with the heart com-
monly involved. Cardiovascular disease (CVD) in SSc
may be direct or indirect, but often remains subclinical.
SSc patients with apparent cardiovascular clinical fea-
tures are at greater risk of deterioration and premature
cardiovascular death, often from complications of myo-
cardial ischaemia. CMR first-pass perfusion detects myo-
cardial ischaemia with great accuracy. We hypothesised
that CMR first-pass perfusion would be able to differ-
entiate between segmental (indicating epicardial coron-
ary artery disease) and non-segmental subendocardial
(indicating microvascular dysfunction) perfusion defects
in patients with SSc; and that microvascular dysfunction
(relating to chronic myocardial inflammation) was more
frequent in SSc.
Methods
17 SSc patients (16 female, mean age 55 ± 9 years) and 17
matched controls (16 female, mean age 54 ± 10 years)
were enrolled. All patients with known cardiovascular dis-
ease were excluded. Study participants underwent CMR at
1.5T and the assessments included cine, tagging, T1 map-
ping, T2-weighted, perfusion, late gadolinium imaging
(0.15mmol/kg gadoderic acid - Dotarem®) and ECV quan-
tification. Comorbid status, disease activity index (VDAI
score) and duration of disease were recorded for each
subject.
Results
Myocardial perfusion reserve index was 1.5 ± 0.3 and
2.0 ± 0.4 (p<0.001) in SSc and controls, respectively.
Non-segmental (circumferential) subendocardial perfu-
sion defects were seen in 41% of SSc and none (p<0.001)
of controls studied. There was no significant difference in
LV size, mass and ejection fraction between SSc patients
and controls. Peak systolic circumferential strain and
peak diastolic strain rate were impaired in patients.
Impaired MPRI correlated with peak systolic strain (R -
0.91, p<0.001) and peak diastolic strain rate (R 0.56,
p<0.001) in SSc. Furthermore, abnormal MPRI correlated
with VDAI (R -0.58, p=0.02) and ECV (R -0.56, p=0.04)
in SSc.
Conclusions
Myocardial perfusion is impaired in asymptomatic SSc
patients with apparently normal hearts. Abnormal perfu-
sion correlates with strain, strain rate, disease activity
and ECV in SSc. CMR can detect subclinical cardiovas-
cular involvement in SSc.
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Table 1 Baseline characteristics of SSc patients and controls
Controls N=17 SSc N=17 P value
Female sex, n (%) 16 (94) 16 (94) 1.00
Age, years 55 ± 9 54 ± 10 0.76
Hypertension, n (%) 1 (6) 4 (24) 0.34
Diabetes, n (%) 0 0 -
Hyperlipidaemia, n (%) 2 (12) 3 (18) 0.63
BMI, kg/m2 24 ± 4 27 ± 7 0.21
Methotrexate, n (%) N/A 5 (29) -
Chloroquine, n (%) N/A 1 (6) -
Leflunomide, n (%) N/A 1 (6) -
Prednisolone, n (%) N/A 1 (6) -
NSAID, n (%) N/A 3 (18) -
HRT/OCP 3 (18) 3 (18) 1.00
mRSS N/A 16 ± 6 -
VDAI N/A 4 (2-5) -
ESR, mm/hr (median, IQR) N/A 11 (8-15) -
CRP, mg/L (median, IQR) 1 (1-2) 6 (3-11) <0.001
Duration of SSc, years (median, IQR) N/A 13 (7-16) -
Duration of DMARDs, years (median, IQR) N/A 4 (2-5) -
Continuous data are mean ± SD unless otherwise indicated.
Categorical data are frequency (percent) unless otherwise indicated.
BMI, body mass index; CRP, C-reactive protein; DMARD, disease modifying anti-rheumatic drug(s); ESR, erythrocyte sedimentation rate; HRT/OCP, hormone
replacement therapy or oral contraceptive pill; IQR, interquartile range; mRSS, modified Rodnan skin score; NSAID, non-steroidal anti-inflammatory drug(s); SSc,
systemic sclerosis; VDAI, Valentini disease activity index
Table 2 Myocardial structure, function and perfusion in SSc patients and controls
Controls N=17 SSc N=17 P value
LVEDV indexed to BSA, ml/m2 78 ± 17 74 ± 11 0.15
LVESV indexed to BSA, ml/m2 21 ± 5 18 ± 5 0.06
LVEF, % 74 ± 6 73 ± 5 0.36
LV Mass indexed to BSA, g/m2 51 ± 12 51 ± 8 0.89
LA size, mm 28 ± 5 37 ± 6 <0.001
Mid SA circumferential strain -18.7 ± 1.0 -17.0 ± 1.7 <0.001
Peak diastolic circumferential strain rate (s-1) 114 ± 16 86 ± 24 <0.001
Presence of LGE (%) 0 10 (59) -
Volume fraction of LGE>2SD (%) 0 2.6 ± 0.3 -
Global myocardial T2 SI Ratio 1.5 ± 0.2 1.7 ± 0.4 0.08
Volume fraction of oedema by T2 (%) 0 18 (7-23) -
Average myocardial T1, ms 958 ± 22 1, 008 ± 28 <0.001
Volume fraction of T1>990ms (%) 0 59 (43-71) -
ECV (%) 27.9 ± 2.4 35.4 ± 4.7 <0.001
Rest RPP 7, 989 ± 1, 280 8, 478 ± 1, 829 0.37
Stress RPP 11, 732 ± 1, 789 11, 980 ± 1, 790 0.69
MPRI 2.0 ± 0.4 1.5 ± 0.3 <0.001
Proportion of non-segmental perfusion defects (%) 0 7 (41) -
Continuous data are mean ± SD unless otherwise indicated.
ECV, extracellular volume; LA, left atrium; LGE, late gadolinium enhancement; LV, left ventricle/ventricular; LVEDV, left ventricular end-diastolic volume; LVEF, left
ventricular ejection fraction; LVESV, left ventricular end-systolic volume; MPRI, myocardial perfusion reserve index; RPP, rate pressure product; SA, short axis; SI,
signal intensity, SSc, systemic sclerosis
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